Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
Diagnostics (Basel, Switzerland)
|
August 29, 2024
Exploring the Multifactorial Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors
Ugo Amicuzi, Marco Grillo, Marco Stizzo, et al.
Therapeutic Advances in Urology
|
August 5, 2025
Artificial intelligence and radiomics applications in adrenal lesions: a systematic review
Matteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, et al.
Medicina (Kaunas, Lithuania)
|
May 27, 2026
Erectile Dysfunction: A Comprehensive Review of Pathophysiology, Diagnosis and Contemporary Management
Felice Crocetto, Ugo Amicuzi, Michele Musone, et al.
Journal of Personalized Medicine
|
April 27, 2024
Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review
Biagio Barone, Luigi Napolitano, Pasquale Reccia, et al.
BJUI Compass
|
January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Anas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
Urologic Oncology
|
September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data
Francesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology
|
June 26, 2024
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs
Francesco Del Giudice, Anas Tresh, Shufeng Li, et al.
Urologic Oncology
|
June 8, 2022
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer
Matteo Ferro, Biagio Barone, Felice Crocetto, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
Minerva Urology and Nephrology
|
October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
Roberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
Diagnostics (Basel, Switzerland)
|
August 29, 2024
Exploring the Multifactorial Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors
Ugo Amicuzi, Marco Grillo, Marco Stizzo, et al.
Therapeutic Advances in Urology
|
August 5, 2025
Artificial intelligence and radiomics applications in adrenal lesions: a systematic review
Matteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, et al.
Medicina (Kaunas, Lithuania)
|
May 27, 2026
Erectile Dysfunction: A Comprehensive Review of Pathophysiology, Diagnosis and Contemporary Management
Felice Crocetto, Ugo Amicuzi, Michele Musone, et al.
Journal of Personalized Medicine
|
April 27, 2024
Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction-A Comprehensive Review
Biagio Barone, Luigi Napolitano, Pasquale Reccia, et al.
BJUI Compass
|
January 29, 2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
Anas S Tresh, Francesco Del Giudice, Shufeng Li, et al.
Urologic Oncology
|
September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data
Francesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology
|
June 26, 2024
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs
Francesco Del Giudice, Anas Tresh, Shufeng Li, et al.
Urologic Oncology
|
June 8, 2022
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer
Matteo Ferro, Biagio Barone, Felice Crocetto, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy
Matteo Ferro, Octavian Sabin Tătaru, Gennaro Musi, et al.
Minerva Urology and Nephrology
|
October 5, 2022
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG
Roberto Contieri, Rodolfo Hurle, Marco Paciotti, et al.
Page
of 13